Earlier quoted context omitted.
> the problem is that fundamental research requires funding In biology, yeah, although I think what a lot of people here are doing is reading stories about high-capital-cost fields (experimental physics, biochem, etc.) and then applying it to their own field, which on HN is mostly computer science. CS research really does not require a lot of funding, outside of specific areas (mostly hardware and robotics stuff). Al…
The biggest cost of my computational grants are funding for people . They don't go away just because you can pay for AWS on a credit card.
Goodbye Academia
161–170 of 217 posts
Re: Goodbye Academia
#162My girlfriend right now is trying to figure out her postdoc in neuroscience. While I fully support her passion, the industry of academia seems completely irrational from almost every sense and full of traps. While the end goal of a tenured professor is exceedingly stable, getting there requires heroic acts of risk, going with the flow and instability that even when compared with the world of startups seems insane. Af…
> While I fully support her passion This is not a criticism of you; I understand you're trying to do your best for someone you care about, which is laudable in itself; but there is something I think needs to be pointed out. You did not say "I fully support her rational and well-informed career choice". Probably you would love to be able to say that but, well, it wouldn't be true. There is a meme floating around at th…
She's well informed about it, and honestly better than the majority of people in the field, but it still doesn't make the field in general a rational decision. In the end her goal isn't to make money or have tenure, but to do science that changes the world; which I admire greatly.
I could say the same about my friend pursuing music professionally (I myself went to school for music, but I'm now in software and far happier)- I went to school with people who probably haven't made $500 in the past year on music, and also with people who won Grammies recently and are at the top of Pitchfork and Billboard's charts. By no means does it make it rational; its a broken system that hasn't caught up to the 21st century, but overall there are still people in it who will do well no matter how hard it is.
On average, you're right however that the best choices are often somewhere in the middle for most of us.
Re: Goodbye Academia
#163Unfortunately, we have way too many highly trained scientists and not enough research funding. Realistically, the only way out of this is increased government funding, and that's not happening anytime soon.
Re: Goodbye Academia
#164Earlier quoted context omitted.
The biggest cost of my computational grants are funding for people . They don't go away just because you can pay for AWS on a credit card.
True, but that's not necessarily the case in biology, where the people are no cheaper, but the experiments are a lot more expensive. Assuming $N of grant is as easy to get in CS as biology (ha!), you'll be able to fund way more people in CS.
Postdocs, and computing time, and grad students, and your salary are all things that need to be supported by grant money.
It might be easier, but to assert it's easy is flawed.
Re: Goodbye Academia
#165Earlier quoted context omitted.
The medical / pharma industry is not interested in cures for diseases; they only want lifelong treatments. True capitalists, seeking maximum profit.
What's the distinction? Whether they sell a thousand symptom suppression pills over a lifetime at $20 or 1 cure pill at $20,000 what does it matter? Are you saying people literally pay by pill count? Patents are monopolies, they don't charge the marignal production cost of one pill while they hold a patent, they charge what the market will pay.
Re: Goodbye Academia
#166Earlier quoted context omitted.
The medical / pharma industry is not interested in cures for diseases; they only want lifelong treatments. True capitalists, seeking maximum profit.
What's the distinction? Whether they sell a thousand symptom suppression pills over a lifetime at $20 or 1 cure pill at $20,000 what does it matter? Are you saying people literally pay by pill count? Patents are monopolies, they don't charge the marignal production cost of one pill while they hold a patent, they charge what the market will pay.
Re: Goodbye Academia
#167It wasn't the money potential, but the lack of opportunities in the field. You can work for less pay if you're compensated for something else in terms of opportunity cost (social status, privilege of doing what you love etc) but right now there's zero incentive and it's so bleak
A lot of my professor friends don't rely purely on salary even if they're tenured. There's other ways like speaking engagements, book royalties etc. I know some tenured professors who don't use grant system at all (especially in humanities) instead they get funding through collaborations and other sources
Re: Goodbye Academia
#168Earlier quoted context omitted.
It's called the tournament model. Big law firms are the classic example. A related theory is that technology and globalization has, and will, make more and more industries 'winner take all'.
I wonder if there are high-profile areas that don't follow that model currently? Given that we're on HN, startups are another example that comes to mind, with the entire VC industry based around trying to hit those rare 100x (or 1000x) exits, and plenty of people happily willing to work towards the small odds of being the one.
Equity/stock traders is one of them because of legislation that fixes the commission price per lot (so the banks cannot really use information asymmetry as an advantage) Not all banking is as profitable as people think it is